Clinical Trials Browser

OTHER × Immunotherapy, Active × Gastrointestinal × Clear all

NCT05247996 2022-02-21

TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma

Phase NA Unknown

Gastrointestinal

Cholangiocarcinoma

NCT03357276 2019-09-12

Mix Vaccine for Metastatic Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms